Non-selective beta-blockers and the incidence of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis

Background: Hepatocellular carcinoma (HCC) is a serious complication of cirrhosis. Currently, non-selective beta-blockers (NSBBs) are commonly used to treat portal hypertension in patients with cirrhosis. The latest research shows that NSBBs can induce apoptosis and S-phase arrest in liver cancer ce...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Xinyi, Zhao, Zimo, Jiang, Xi, Sun, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394622/
https://www.ncbi.nlm.nih.gov/pubmed/37538177
http://dx.doi.org/10.3389/fphar.2023.1216059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394622/
https://www.ncbi.nlm.nih.gov/pubmed/37538177
http://dx.doi.org/10.3389/fphar.2023.1216059

Ejemplares similares